Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.21.2
Commitments and Contingencies (Details Narrative)
6 Months Ended
Nov. 03, 2020
Dec. 13, 2019
EUR (€)
shares
Dec. 13, 2019
USD ($)
$ / shares
shares
Jun. 30, 2021
EUR (€)
Jun. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
Total Long-Term Debt           $ 3,042,117  
Payments for future research and collobration           964,099  
Short term lease costs         $ 37,417    
Aggerate amount payable, description the Company to pay in aggregate of up to $2.9 million over a period of 22 months.            
Amount payable           308,692  
Operating lease right-of-use assets           318,393 $ 326,085
In 2018 [Member] | Finance Lease Obligations [Member] | BNP Paribas leasing solutions [Member]              
Amount payable           $ 6,460  
Purchase price for the property | €       € 25,000      
Maturity date       Jan. 31, 2022 Jan. 31, 2022    
Implicit interest       1.35%   1.35%  
Leased equipment amortized term       5 years 5 years    
In 2019 [Member] | Taxes A&M University [Member]              
Repayment of long-term loan amount         $ 400,000    
Loan agreement term       5 years 5 years    
Collaborative obligations amount due           $ 122,123  
In 2019 [Member] | Collaborative Arrangement, Co-promotion [Member]              
Collaborative obligations amount due           0  
Research collaboration agreement description       Company entered into a research collaboration agreement with the University of Taiwan for a two-year period to collect a total of 1,200 samples for a cost to the Company of up to $320,000 payable over such period. Company entered into a research collaboration agreement with the University of Taiwan for a two-year period to collect a total of 1,200 samples for a cost to the Company of up to $320,000 payable over such period.    
January 10, 2020 [Member]              
Common stock, restricted shares issued in exchange of purchased outstanding shares, value     $ 333,969        
Restricted shares issued | shares   73,263 73,263        
Common stock, restricted shares issued in exchange of purchased outstanding shares, shares | shares   73,263 73,263        
Weighted trading price per share | $ / shares     $ 4.56        
Repayment of debt | €   € 350,000          
Common stock adjusted amount     $ 357,000        
Holdback period       9 months 9 months    
Holdback liabilities           55,404  
Net liabilities     $ 43,152        
Walloon Region Government [Member] | In 2020 [Member]              
Amount payable           $ 61,254  
Terms of agreement description       The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received.    
Repayment of grants | €       € 148,500      
Grant receivable | €       € 495,000      
Fixed interest rate on lease       2.89%   2.89%  
Walloon Region Government [Member] | In 2010 [Member]              
Amount payable           $ 65,183  
Repayment of long-term loan amount | €       € 315,788      
Terms of agreement description       it is due to pay a 6% royalty on such revenue to the Walloon Region. it is due to pay a 6% royalty on such revenue to the Walloon Region.    
Repayment of grants | €       € 314,406      
Grant receivable | €       € 1,050,000.00      
Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member] | In 2020 [Member]              
Amount payable           $ 55,040  
Terms of agreement description       The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received    
Repayment of grants | €       € 278,830      
Grant receivable | €       € 929,433      
Fixed interest rate on lease       4.34%   4.34%  
Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member] | In 2018 [Member]              
Amount payable           $ 127,215  
Terms of agreement description       The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received.    
Repayment of grants | €       € 181,500      
Grant receivable | €       € 605,000      
ING [Member] | In 2016 [Member] | Long-term Debt [Member]              
Fixed interest rate on lease       2.62%   2.62%  
Lease payable           $ 606,213  
Purchase price for the property | €       € 1,120,000      
DKFZ [Member] | In 2016 [Member] | Research Co-operation Agreement [Member]              
Collaborative obligations amount due           237,029  
Lease agreement expire period       5 years 5 years    
Collaborative obligations amount | €       € 400,000      
University of Taiwan [Member] | In 2018 [Member] | Clinical Study Research Agreement [Member]              
Collaborative obligations amount due           510,000  
Lease agreement expire period       3 years 3 years    
Collaborative obligations amount           2,550,000  
Managing Director's Agreement [Member]              
Amount payable           $ 229  
Royalty payment         $ 85,330    
Royality       6.00% 6.00%    
Stock based compensation expenses         $ 753,000    
Managing Director's Agreement [Member] | Founder [Member]              
Fixed interest rate       6.00%   6.00%  
Repayment of long-term loan amount | €       € 8,000      
Loan Agreement [Member] | ING [Member] | In 2016 [Member] | Long-term Debt [Member]              
Fixed interest rate       2.62%   2.62%  
Repayment of long-term loan amount | €       € 270,000      
Total long-term debt           $ 8,224  
Loan agreement term       15 years 15 years    
Loan Agreement [Member] | Namur [Member] | October 13, 2020 [Member] | Long-term Debt [Member]              
Fixed interest rate       4.00%   4.00%  
Repayment of long-term loan amount | €       € 830,000      
Maturity date       March 2031 March 2031    
Total long-term debt           $ 963,562  
Loan agreement term       10 years 10 years    
Loan Agreement [Member] | Namur Invest [Member] | In 2016 [Member] | Long-term Debt [Member]              
Fixed interest rate       4.85%   4.85%  
Repayment of long-term loan amount | €       € 440,000      
Maturity date       December 2031 December 2031    
Total long-term debt           $ 220,175  
Loan agreement term       7 years 7 years    
Loan Agreement [Member] | Namur Invest [Member] | In 2019 [Member] | Long-term Debt [Member]              
Fixed interest rate       4.80%   4.80%  
Repayment of long-term loan amount | €       € 500,000      
Maturity date       September 2024 September 2024    
Total long-term debt           $ 553,460  
Loan agreement term       4 years 4 years    
Loan Agreement [Member] | Namur Invest [Member] | In 2017 [Member] | Long-term Debt [Member]              
Fixed interest rate       4.00%   4.00%  
Repayment of long-term loan amount | €       € 350,000      
Maturity date       June 2021 June 2021    
Total long-term debt           $ 0  
Loan agreement term       4 years 4 years    
Loan Agreement [Member] | SOFINEX [Member] | In 2017 [Member] | Long-term Debt [Member]              
Fixed interest rate       4.50%   4.50%  
Repayment of long-term loan amount | €       € 1,000,000      
Maturity date       September 2024 September 2024    
Total long-term debt           $ 888,857  
Loan agreement term       7 years 7 years    
Bioinformatic Analytics Of Cell Free DNA [Member] | On September 16, 2020 [Member]              
Repayment of long-term loan amount | €       € 54,879      
Total long-term debt           94,947  
Additional cost of company         $ 155,115    
TAMU [Member] | October 25, 2019 [Member]              
Non-controlling interest       7.50% 7.50%    
Equity interest       12.50% 12.50%    
Additional interest       5.00% 5.00%    
Operating Lease Right of Use Obligations [Member]              
Short term lease costs         $ 323,996    
Operating lease right-of-use assets           $ 318,393  
Weighted average discount rate       4.49%   4.49%  
Weighted average remaining lease term       33 months 33 months    
Payment of lease liabilities         $ 44,059    
Operating lease expense         $ 44,355    
Namur Innovation and Growth [Member] | Loan Agreement [Member] | In 2018 [Member] | Long-term Debt [Member]              
Fixed interest rate       4.00%   4.00%  
Repayment of long-term loan amount | €       € 500,000      
Maturity date       June 2022 June 2022    
Total long-term debt           $ 177,839  
Loan agreement term       4 years 4 years